Feb 17, 2026 06:28AM

Jan 12, 2026 02:27AM

Jan 7, 2026 01:20PM

Jan 5, 2026 09:51AM

Jan 5, 2026 06:45AM

Dec 1, 2025 05:08AM

Nov 17, 2025 04:24AM Neumora Therapeutics (NMRA) PT Raised to $3 at Stifel

Nov 6, 2025 08:19AM

Oct 27, 2025 07:57AM

Oct 27, 2025 06:30AM

Oct 23, 2025 06:50AM

Sep 15, 2025 04:41PM

Aug 7, 2025 10:00AM

Aug 6, 2025 05:09PM Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 12c

Jul 16, 2025 05:52AM

Jul 10, 2025 06:50AM

Jul 9, 2025 07:03AM

May 13, 2025 07:05AM

Apr 29, 2025 07:28AM

Apr 16, 2025 01:02PM

Apr 7, 2025 12:55PM FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Apr 5, 2025 01:11PM

Apr 4, 2025 12:35PM

Apr 3, 2025 04:00PM

Apr 2, 2025 04:04PM

Apr 2, 2025 01:38AM

Apr 2, 2025 01:10AM

Apr 1, 2025 08:35PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Apr 1, 2025 01:55PM

Mar 31, 2025 08:30PM

Mar 29, 2025 04:32PM

Mar 28, 2025 04:32PM

Mar 28, 2025 04:00PM

Mar 27, 2025 04:27PM

Mar 27, 2025 11:18AM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 26, 2025 04:22PM

Mar 24, 2025 04:13PM

Mar 23, 2025 04:00PM

Mar 23, 2025 02:02PM

Mar 22, 2025 12:23PM

Mar 21, 2025 12:18PM

Mar 19, 2025 07:07PM ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 18, 2025 07:02PM

Mar 17, 2025 06:56PM

Mar 17, 2025 04:00PM

Mar 17, 2025 02:27PM

Mar 16, 2025 06:57PM

Mar 15, 2025 06:57PM

Mar 14, 2025 06:52PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 11, 2025 09:40PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All